[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Tscan Therapeutics Inc (TCRX)

Tscan Therapeutics Inc (TCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 64,952
  • Shares Outstanding, K 65,351
  • Annual Sales, $ 10,330 K
  • Annual Income, $ -129,770 K
  • EBIT $ -129 M
  • EBITDA $ -126 M
  • 60-Month Beta 1.03
  • Price/Sales 6.21
  • Price/Cash Flow N/A
  • Price/Book 0.61
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.96
  • Most Recent Earnings $-0.22 on 05/06/26
  • Next Earnings Date 08/11/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.27
  • Number of Estimates 4
  • High Estimate $-0.20
  • Low Estimate $-0.44
  • Prior Year $-0.28
  • Growth Rate Est. (year over year) +3.57%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.9400 +2.71%
on 06/03/26
1.3100 -26.30%
on 05/11/26
-0.2945 (-23.37%)
since 05/08/26
3-Month
0.9200 +4.95%
on 03/30/26
1.4700 -34.32%
on 04/20/26
-0.2745 (-22.14%)
since 03/09/26
52-Week
0.8824 +9.42%
on 12/19/25
2.5700 -62.43%
on 10/16/25
-0.8045 (-45.45%)
since 06/09/25

Business Summary

TScan Therapeutics Inc. is a biopharmaceutical company. It focused on the development of T-cell receptor engineered T cell therapies for the treatment of patients with cancer. The company's lead product pipeline consist TSC-100 and TSC-101. TScan Therapeutics Inc. is based in WALTHAM, Mass.

See More

Key Turning Points

3rd Resistance Point 1.0803
2nd Resistance Point 1.0552
1st Resistance Point 1.0103
Last Price 0.9655
1st Support Level 0.9403
2nd Support Level 0.9152
3rd Support Level 0.8703

See More

52-Week High 2.5700
Fibonacci 61.8% 1.9253
Fibonacci 50% 1.7262
Fibonacci 38.2% 1.5271
Last Price 0.9655
52-Week Low 0.8824

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.